Wealthfront Advisers LLC Buys New Position in Astera Labs, Inc. $ALAB

Wealthfront Advisers LLC purchased a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 2,794 shares of the company’s stock, valued at approximately $1,350,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ALAB. Glenmede Trust Co. NA raised its stake in shares of Astera Labs by 2.7% during the first quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after purchasing an additional 51 shares during the period. Lido Advisors LLC boosted its stake in shares of Astera Labs by 0.5% in the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock valued at $2,046,000 after purchasing an additional 57 shares during the period. Goldstein Advisors LLC boosted its stake in shares of Astera Labs by 5.8% in the fourth quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock valued at $268,000 after purchasing an additional 88 shares during the period. Bell Investment Advisors Inc acquired a new stake in Astera Labs during the 2nd quarter valued at $43,000. Finally, Great Valley Advisor Group Inc. grew its holdings in Astera Labs by 2.2% during the 2nd quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock valued at $372,000 after purchasing an additional 90 shares in the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on ALAB shares. Morgan Stanley boosted their price objective on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a report on Monday, August 3rd. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday. Zacks Research raised Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Susquehanna boosted their price target on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Finally, Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price target on the stock in a research note on Monday, August 17th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $333.00.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 90,630 shares of Astera Labs stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 419,244 shares of company stock worth $163,135,169 over the last quarter. 10.40% of the stock is owned by corporate insiders.

Astera Labs Stock Performance

Shares of Astera Labs stock opened at $284.97 on Friday. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The firm’s 50-day simple moving average is $352.70 and its 200-day simple moving average is $244.92. The firm has a market cap of $49.44 billion, a PE ratio of 141.07 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s revenue for the quarter was up 104.5% compared to the same quarter last year. During the same period last year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.